Jean‐Marc Brisson
Publications by Year
Research Areas
Analytical Chemistry and Chromatography, Pesticide Residue Analysis and Safety, Mass Spectrometry Techniques and Applications, Hepatitis C virus research, Analytical Methods in Pharmaceuticals
Most-Cited Works
- → Discovery of (1 R ,5 S )- N -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( S )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( S )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection(2006)278 cited
- → Quantitative screening and matrix effect studies of drug discovery compounds in monkey plasma using fast‐gradient liquid chromatography/tandem mass spectrometry(2001)135 cited
- → High-Performance Liquid Chromatography-Atmospheric Pressure Photoionization/Tandem Mass Spectrometric Analysis for Small Molecules in Plasma(2003)81 cited
- → Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high‐performance liquid chromatography/tandem mass spectrometry(2002)78 cited
- → Fused-Core Silica Column High-Performance Liquid Chromatography/Tandem Mass Spectrometric Determination of Rimonabant in Mouse Plasma(2007)73 cited
- → Direct cocktail analysis of drug discovery compounds in pooled plasma samples using liquid chromatography–tandem mass spectrometry(2002)59 cited
- → Discovery of SCH446211 (SCH6): A New Ketoamide Inhibitor of the HCV NS3 Serine Protease and HCV Subgenomic RNA Replication(2006)59 cited
- → Direct analysis of plasma samples for drug discovery compounds using mixed‐function column liquid chromatography tandem mass spectrometry(2000)49 cited
- → Porous graphitic carbon chromatography/tandem mass spectrometric determination of cytarabine in mouse plasma(2007)31 cited
- → Simultaneous fast HPLC-MS/MS analysis of drug candidates and hydroxyl metabolites in plasma(2003)25 cited